Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
72.74 CAD | -1.72% | +1.86% | -2.55% |
29/04 | Berenberg Upgrades Nutrien to Buy From Hold, Price Target is $66 | MT |
29/04 | Berenberg Upgrades Nutrien to Buy From Hold, Raises Price Target to $66 From $60 | MT |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.55% | 26.82B | B+ | ||
-4.40% | 790M | - | C+ | |
+24.48% | 724M | - | ||
-33.87% | 625M | - | - | |
-12.00% | 330M | - | - | |
-10.26% | 210M | - | - | |
-.--% | 101M | - | - | |
+23.98% | 80.84M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NTR Stock
- Ratings Nutrien Ltd.